Human HMGB1 ELISA Kit | EL-213-813701

Cat. No: EL-213-813701

$859.99 USD

96 wells

1
Target proteinHMGB1
Gene ID3146
ReactivityHuman
Detection range62.5-4000 pg/mL
Sample typeserum, plasma and other biological fluids
Sample volume100 µL
Assay time3h 20min
PrecisionIntra-assay CV <8%. Inter-assay CV <10%
ComponentsPre-Coated Microplate - 12 strips x 8 wells (4°C/-20°C)
Standard (Lyophilized) - 2 vials (4°C/-20°C)
Biotinylated Antibody (100×) - 120 μL (4°C/-20°C)
Streptavidin-HRP (100×) - 120 μL (4°C/-20°C)
Standard/Sample Diluent Buffer - 20 mL (4°C/-20°C)
Biotinylated Antibody Diluent - 12 mL (4°C/-20°C)
HRP Diluent - 12 mL (4°C/-20°C)
Wash Buffer (25×) - 20 mL (4°C/-20°C)
TMB Substrate Solution - 10 mL (4°C/-20°C (store in dark))
Stop Reagent - 6 mL (4°C/-20°C)
Plate Covers - 2 pieces (RT)
Storage4°C/-20°C

Download product sheet (PDF)

Safety Warning: Research Use Only. Not for diagnostic use.

This kit employs a sandwich enzyme immunoassay technique to quantify HMGB1 in biological samples.

Introduction

HMGB1 is a nonhistone chromatin protein that, inside the nucleus, helps bend and organize DNA to support replication, transcription, chromatin remodeling, and repair processes such as V(D)J recombination. When cells are stressed, dying, or activated, HMGB1 can be released passively from necrotic or pyroptotic cells or actively secreted by immune cells, and outside the cell it behaves as a damage-associated molecular pattern that signals tissue injury to the immune system. Depending on its oxidation state, extracellular HMGB1 can act more like a chemokine that recruits inflammatory cells, a cytokine that triggers NF-kB-driven release of factors such as TNF and IL-6 through receptors including RAGE and Toll-like receptors, or a tolerogenic signal associated with apoptotic clearance. Because of this dual nuclear and extracellular role, HMGB1 has been linked to processes ranging from normal genome maintenance to tumor cell migration and the broader inflammatory response seen in sepsis, trauma, and other acute injury states.

Principle of the Assay

This kit uses a sandwich enzyme immunoassay format in which the microtiter plate wells are pre-coated with a capture antibody specific to Human HMGB1. During incubation, HMGB1 present in standards or samples is captured by this immobilized antibody, followed by addition of a biotin-conjugated detection antibody that recognizes a distinct epitope on the bound analyte. Avidin-conjugated horseradish peroxidase (HRP) is then added to each well, where it binds the biotin label. Upon addition of TMB substrate solution, a colorimetric signal develops exclusively in wells containing Human HMGB1, biotin-conjugated antibody, and Avidin-HRP conjugate. The enzymatic reaction is stopped by addition of a sulphuric acid solution, and absorbance is measured at 450 nm (± 10 nm). Sample concentrations are determined by comparing the optical density of each sample against a standard curve.